Poland

BMI View: The worst of the pharmaceutical market downturn last year may be behind drugmakers operating in Poland. A consultation launched by the Ministry of Health and the enforcement... 2013-01-23

BMI View: The entry of UK firm Bupa into the Polish private healthcare market highlights the increasing dynamism of the sector in Central and Eastern Europe (CEE). Economic liberalisation... 2013-01-02

BMI View: In our Q113 assessment, we have revised downward our Pharmaceuticals and Healthcare Risk/Reward Ratings (RRRs) for Central and Eastern Europe (CEE), mainly due to the attractiveness... 2012-10-03

BMI View: Poland's strengthening domestic drug industry will continue to boost its international exposure in the years to come. Nonetheless, Poland still lags behind its Western European... 2012-10-01

BMI View: Poland's over-the-counter (OTC) medicine market will outperform the prescription drugs market significantly over our forecast period to 2016. While reimbursed prescription... 2012-09-05

BMI View: It is discouraging that Poland's National Health Fund does not plan on increasing expenditure on reimbursed pharmaceuticals in 2013, despite moderately increasing funding... 2012-08-20

BMI View: Recordati's purchase of Polish company Farma-Projekt will boost the Italian firm's presence in Poland and Central and Eastern Europe and aligns with its existing strategy... 2012-08-06